Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: A prospective, non-randomised, single-centre study

The Lancet Oncology

Volumn 15, Issue 3, 2014, Pages 275-285

  Klenk, Christopher ^a   Gawande, Rakhee ^a   Uslu, Lebriz ^a   Khurana, Aman ^a   Qiu, Deqiang ^a   Quon, Andrew ^a   Donig, Jessica ^a   Rosenberg, Jarrett ^a   Luna Fineman, Sandra ^b   Moseley, Michael ^a   Daldrup Link, Heike E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERUMOXYTOL; FLUORODEOXYGLUCOSE F 18; IRON;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FOLLOW UP; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; INTERMETHOD COMPARISON; IONIZING RADIATION; LYMPHOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE SCANNER; OFF LABEL DRUG USE; PATHOLOGICAL ANATOMY; PET SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION EXPOSURE; SARCOMA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WHOLE BODY MRI; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; MULTIMODAL IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84896733367     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70021-X     Document Type: Article

References (37)

1. Robbins E Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer 2008, 51:453-457.
2. Huang B, Law MW, Khong PL Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 2009, 251:166-174.
3. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 2003, 100:13761-13766.
4. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2 2006, National Research Council, The National Academies Press, Washington, DC.
5. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
6. Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013, 346:f2360.
7. Jagadeesh D, Diefenbach C, Evens AM XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes. Hematol Oncol 2013, 31(suppl 1):69-755.
8. Kellenberger CJ, Epelman M, Miller SF, Babyn PS Fast STIR whole-body MR imaging in children. Radiographics 2004, 24:1317-1330.
9. Kwee TC, van Ufford HM, Beek FJ, et al. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 2009, 44:683-690.
10. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008, 18:1937-1952.
11. Padhani AR, Koh DM, Collins DJ Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011, 261:700-718.
12. Matasar MJ, Zelenetz AD Overview of lymphoma diagnosis and management. Radiol Clin North Am 2008, 46:175-198.
13. The 2007 recommendations of the International Commission on Radiological Protection. ICRP Publication 103 ICRP, (accessed Jan 21, 2014). http://www.icrp.org/publication.asp?id=ICRP%20Publication%20103.
14. Deak PD, Smal Y, Kalender WA Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology 2010, 257:158-166.
15. Gawande RS, Gonzalez G, Messing S, Khurana A, Daldrup-Link HE Role of diffusion-weighted imaging in differentiating benign and malignant pediatric abdominal tumors. Pediatr Radiol 2013, 43:836-845.
16. Pepe M, Longton G, Janes H Estimation and comparison of receiver operating characteristic curves. Stata J 2009, 9:1.
17. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002, 12:1557-1566.
18. Ording Muller LS, Avenarius D, Olsen OE High signal in bone marrow at diffusion-weighted imaging with body background suppression (DWIBS) in healthy children. Pediatr Radiol 2011, 41:221-226.
19. van Ufford HM, Kwee TC, Beek FJ, et al. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. AJR Am J Roentgenol 2011, 196:662-669.
20. Naganawa S, Sato C, Nakamura T, et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 2005, 21:836-840.
21. Hassan N, Cahill J, Rajasekaran S, Kovey K Ferumoxytol infusion in pediatric patients with gastrointestinal disorders: first case series. Ann Pharmacother 2011, 45:e63.
22. Lu M, Cohen MH, Rieves D, Pazdur R FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 2010, 85:315-319.
23. Auerbach M, Strauss W, Auerbach S, Rineer S, Bahrain H Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol 2013, 88:944-947.
24. Vermoolen MA, Kersten MJ, Fijnheer R, van Leeuwen MS, Kwee TC, Nievelstein RA Magnetic resonance imaging of malignant lymphoma. Expert Rev Hematol 2011, 4:161-171.
25. Luna A, Sanchez-Gonzalez J, Caro P Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am 2011, 19:69-94.
26. Heesakkers RA, Hovels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 2008, 9:850-856.
27. Triantafyllou M, Studer UE, Birkhauser FD, et al. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer 2013, 49:616-624.
28. Birkhauser FD, Studer UE, Froehlich JM, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 2013, 64:953-960.
29. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009, 55:761-769.
30. Luscieti P, Hubschmid T, Cottier H, Hess MW, Sobin LH Human lymph node morphology as a function of age and site. J Clin Pathol 1980, 33:454-461.
31. Ramsay AD Reactive lymph nodes in pediatric practice. Am J Clin Pathol 2004, 122(suppl):S87-975.
32. Hadamitzky C, Spohr H, Debertin AS, Guddat S, Tsokos M, Pabst R Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance?. J Anat 2010, 216:556-562.
33. Foster K, Chapman S, Johnson K MRI of the marrow in the paediatric skeleton. Clin Radiol 2004, 59:651-673.
34. Chawla SC, Federman N, Zhang D, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol 2010, 40:681-686.
35. Gelfand MJ, Sharp SE, Treves ST, Fahey FH, Parisi MT, Alessio AM Estimated cumulative radiation dose from PET/CT in children with malignancies. Pediatr Radiol 2010, 40:1712-1713.
36. Fahey FH Dosimetry of pediatric PET/CT. J Nucl Med 2009, 50:1483-1491.
37. Radiological protection in medicine. ICRP Publication 105 ICRP, (accessed Jan 22, 2014). http://www.icrp.org/publication.asp?id=ICRP%20Publication%20105.